On 15 January 2025, the US Food and Drug Administration (FDA) announced that it will revoke the color additive authorization ...

Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris ...

A rather historic U.S. Food and Drug Administration (FDA) proposal aims to make cigarettes and other tobacco products far ...

Altria has targeted a certain annual dividend increase. Its core business remains under pressure. Smokeable-product volume has continued to fall. Generating income from dividends can prove very ...

Altria (NYSE: MO) owns the Marlboro brand, which has a roughly 41% market share in North America. That's huge and highlights the company's dominance in this geographic region. But the downside ...

Bearish flow noted in Altria Group (MO) with 11,600 puts trading, or 3x expected. Most active are Mar-25 50 puts and Feb-25 55 calls, with total volume in those strikes near 9,900 contracts.

Altria Group Inc. Altria Group (MO ... saw success recently with the Food and Drug Administration approval of the schizophrenia drug Cobenify. This puts the company in a good position to continue ...

Altria Group, Inc. MO stock is currently trading at a forward 12-month price-to-earnings (P/E) ratio of 9.85, representing a 16.9% discount compared to the Zacks Tobacco industry’s average of 11.85.

In normal times I might respect that nice sentiment, but not with this incoming Trump administration. I want them to fail at every horrible thing they try to do. Does wishing them well include ...